EQUITY OFFERINGS AND REPURCHASES AND RELATED EXPENSES (Details) - USD ($) |
3 Months Ended | 6 Months Ended | 12 Months Ended | 169 Months Ended | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 09, 2025 |
Aug. 11, 2023 |
Nov. 16, 2021 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Mar. 31, 2025 |
Jun. 30, 2026 |
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
Dec. 31, 2018 |
Dec. 31, 2017 |
Dec. 31, 2014 |
Dec. 31, 2013 |
Dec. 31, 2012 |
Jun. 30, 2026 |
Mar. 03, 2026 |
||||
| EQUITY OFFERINGS AND RELATED EXPENSES | ||||||||||||||||||||||||
| Aggregate offering price | [1] | $ 3,822,916 | $ 8,938,086 | |||||||||||||||||||||
| Common stock, par value | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | ||||||||||||||||||||
| Issuance of common stock, net of offering costs (shares) | 1,466,136 | 3,355,476 | 4,458,873 | 149,174 | 31,592 | 354,257 | 3,177,936 | 7,931 | 3,465,922 | 380,936 | 63,998 | 12,035,023 | 28,947,254 | |||||||||||
| Share repurchase authorized amount | $ 20,000,000 | |||||||||||||||||||||||
| Repurchase of common stock (in shares) | 274,343 | 274,343 | ||||||||||||||||||||||
| Repurchase of common stock | $ 2,447,682 | [1] | $ 2,447,682 | |||||||||||||||||||||
| Weighted average net repurchase price | $ 8.92 | $ 8.92 | ||||||||||||||||||||||
| Equity Distribution Agreement | ||||||||||||||||||||||||
| EQUITY OFFERINGS AND RELATED EXPENSES | ||||||||||||||||||||||||
| Aggregate offering price | $ 100,000,000 | $ 100,000,000 | $ 50,000,000 | |||||||||||||||||||||
| Common stock, par value | $ 0.001 | $ 0.001 | $ 0.001 | |||||||||||||||||||||
| ||||||||||||||||||||||||
| X | ||||||||||
- Definition Weighted average price at which the shares were repurchased. No definition available.
|
| X | ||||||||||
- Definition Amount authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of shares that have been repurchased and retired during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|